首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1782082

药用及芳香植物市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Medicinal and Aromatic Plant Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年07月01日 | 出版商:

Global Market Insights Inc. | 英文 245 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024年，全球药用和芳香植物市场价值达4,103亿美元，预计到2034年将以8.1%的复合年增长率成长，达到8,907亿美元。这一强劲成长趋势的动力源自于消费者对天然植物性健康产品日益增长的兴趣。越来越多的人正在寻求用于预防和治疗目的的整体有机解决方案。全球对草药补充剂、精油和植物性个人护理用品的需求持续增长。这些植物在多个行业中都至关重要，在替代医学、心理健康和护肤领域具有治疗功效。它们在促进整体健康和情绪平衡方面的作用已得到广泛认可，促使製造商和消费者共同探索其全部潜力。

药用植物和芳香植物广泛应用于製药、食品饮料和化妆品领域。在製药业，它们是创造传统和现代药物配方的重要原料。它们也被纳入食品饮料行业的调味系统和营养成分中。在化妆品领域，它们的天然芳香化合物有助于开发护肤和保健产品。提取技术、有机种植实践和生态意识采收的进步进一步推动了市场扩张。消费者对清洁标籤、绿色和植物性替代品的偏好仍然对市场需求产生强烈影响。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	4103亿美元
预测值	8907亿美元
复合年增长率	8.1%

2024年，药用植物市场占据了64.8%的市场份额，预计到2034年将以8%的复合年增长率成长。药用植物的重要性日益提升，源自于其在从传统疗法到现代补充剂和药物等一系列医疗体系中的持续应用。这些植物被广泛用于治疗发炎、感染和慢性疾病，吸引了全球市场製造商和消费者的持续关注。

2024年，製药业的市值达到1,653亿美元，预计未来十年将以8.4%的复合年增长率快速成长。随着医疗保健产业为满足日益增长的治疗需求而快速发展，药用植物越来越多地被纳入新的药物配方、草药疗法和预防性治疗中。该产业对持续研发的重视进一步推动了对植物投入品的需求。

美国药用和芳香植物市场占最大份额，2024年价值823亿美元，预计到2034年复合年增长率为6.3%。强大的农业和分销基础设施确保了药用和芳香植物领域可靠的供应链和高品质的产出。消费者对草药、非合成药物的偏好很高，这得益于值得信赖的监管环境，确保了产品的品质和安全。

塑造该市场竞争格局的知名公司包括 Forest Essential、Emami Limited、doTERRA International、Givaudan SA 和 Dabur India Limited。为了确保竞争优势，药用和芳香植物市场的公司正专注于垂直整合和对有机农业实践的投资。许多公司正在扩大生产设施，与当地种植者合作，并提升加工能力，以确保一致的品质和可追溯性。他们也利用萃取和纯化方面的技术进步来提供高效的植物成分。透过清洁标籤、永续采购和供应链透明度来建立信任仍然是核心。此外，各公司正透过客製化产品线和策略合作瞄准国际市场，以扩大全球影响力并巩固其市场地位。

产业生态系统分析
- 供应商格局
- 利润率
- 每个阶段的增值
- 影响价值链的因素
- 中断
产业衝击力
- 成长动力
  - 对天然和有机产品的需求不断增长
  - 提高医疗保健意识和预防医学
  - 製药业采用率不断上升
- 产业陷阱与挑战
  - 供应链漏洞
  - 气候变迁对种植业的影响
- 市场机会
成长潜力分析
监管格局
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东和非洲
波特的分析
PESTEL分析
价格趋势
- 按地区
- 按植物类型
未来市场趋势
技术和创新格局
- 当前的技术趋势
- 新兴技术
专利态势
贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
- 主要进口国
- 主要出口国
永续性和环境方面
- 永续实践
- 减少废弃物的策略
- 生产中的能源效率
- 环保倡议

第四章：竞争格局

介绍
公司市占率分析
- 按地区
  - 北美洲
  - 欧洲
  - 亚太地区
  - 拉丁美洲
  - MEA
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
关键进展
- 併购
- 伙伴关係与合作
- 新产品发布
- 扩张计划

第五章：市场估计与预测：依工厂类型，2021-2034

主要趋势
药用植物
- 适应原植物
  - Ashwagandha（睡茄）
  - 人参（人参属）
  - 红景天（Rhodiola rosea）
- 抗发炎植物
  - 姜黄（Curcuma longa）
  - 生姜（Zingiber officinale）
  - 乳香树（齿叶乳香树）
- 消化健康植物
  - 芦荟（库拉索芦荟）
  - 薄荷（Mentha piperita）
  - 洋甘菊（Matricaria chamomilla）
- 呼吸健康植物
  - 桉树（蓝桉）
  - 百里香（Thymus vulgaris）
  - 甘草（Glycyrrhiza glabra）
- 心血管健康植物
- 免疫支持植物
- 认知健康植物
芳香植物
- 精油植物
  - 熏衣草（Lavandula angustifolia）
  - 茶树（互叶白千层）
  - 迷迭香（Rosmarinus officinalis）
  - 牛至（Origanum vulgare）
- 芳香植物
  - 玫瑰（蔷薇属）
  - 茉莉花（茉莉属）
  - 檀香木（檀香木）
- 烹饪香草
  - 罗勒（Ocimum basilicum）
  - 鼠尾草（Salvia officinalis）
  - 肉桂（肉桂属）

第六章：市场估计与预测：依产品形式，2021-2034

主要趋势
原料
- 新鲜植物和草药
- 干燥植物和粉末
- 植物各部位（根、叶、花、种子）
萃取物和浓缩物
- 标准化萃取物
- 液体萃取物和酊剂
- 浓缩粉
- 油树脂和树脂
精油
- 纯精油
- 混合精油
- 有机精油
- 治疗级油
製成品
- 胶囊和片剂
- 液体製剂
- 局部应用
- 功能性食品

第七章：市场估计与预测：按应用，2021-2034

主要趋势
製药业
- 药物开发与製造
- 营养保健品和膳食补充剂
- 传统药物配方
- 临床研究与开发
化妆品和个人护理
- 保养产品
- 护髮产品
- 香水和香料
- 天然和有机化妆品
食品和饮料业
- 功能性食品和饮料
- 天然调味剂
- 食品保鲜和添加剂
- 草本茶和冲泡茶
芳香疗法与健康
- 精油疗法
- 水疗和健康中心
- 家用香熏产品
- 治疗应用
农业和兽医
- 生物农药和植物保护
- 动物健康和营养
- 有机农业应用
- 土壤健康与改良

第八章：市场估计与预测：以种植方式，2021-2034 年

主要趋势
常规种植
- 传统耕作方法
- 商业种植系统
- 综合农业方法
有机栽培
- 经过认证的有机生产
- 生物动力农业
- 自然耕作法
野生采伐
- 永续野生采集
- 森林采伐
- 社区收集
受控环境农业
- 温室栽培
- 水耕系统
- 垂直农业应用
- 组织培养和微繁殖

第九章：市场估计与预测：按地区，2021-2034

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第十章：公司简介

Dabur India Limited
doTERRA International
Emami Limited
Forest Essentials
Givaudan SA
Himalaya Drug Company
Kama Ayurveda
Khadi Natural
Patanjali Ayurved Limited
Shahnaz Husain
Symrise AG
Tongrentang
Young Living Essential Oils

简介目录

Product Code: 14354

The Global Medicinal and Aromatic Plant Market was valued at USD 410.3 billion in 2024 and is estimated to grow at a CAGR of 8.1% to reach USD 890.7 billion by 2034. This strong upward trend is powered by growing consumer interest in natural, plant-based wellness products. More people are seeking holistic and organic solutions for both preventive and therapeutic purposes. The demand for herbal supplements, essential oils, and botanically derived personal care items continues to rise globally. These plants are essential in multiple industries, offering healing benefits in alternative medicine, mental wellness, and skincare. Their role in promoting overall health and emotional balance is widely recognized, pushing manufacturers and consumers alike to explore their full potential.

Medicinal and Aromatic Plant Market - IMG1

Medicinal and aromatic plants are widely used across the pharmaceutical, food and beverage, and cosmetics sectors. In pharma, they act as vital inputs for creating both traditional and modern medicinal formulations. They are also incorporated into flavor systems and nutritional ingredients across the F&B industry. On the cosmetic front, their natural aromatic compounds help develop skincare and wellness products. Advances in extraction technologies, organic cultivation practices, and eco-conscious harvesting have further supported market expansion. The demand remains strongly influenced by consumer preference for clean-label, green, and plant-based alternatives.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$410.3 Billion
Forecast Value	$890.7 Billion
CAGR	8.1%

In 2024, the medicinal plants segment captured 64.8% share and is forecast to grow at a CAGR of 8% through 2034. Their rising importance stems from their continued use in a range of health systems, from traditional therapies to contemporary supplements and pharmaceuticals. These plants are extensively employed to address inflammation, infections, and chronic illnesses, drawing steady interest from manufacturers and consumers across global markets.

The pharmaceutical sector generated a market value of USD 165.3 billion in 2024 and is anticipated to grow at a faster CAGR of 8.4% over the next decade. As the healthcare sector rapidly evolves to meet growing needs for treatment options, medicinal plants are increasingly integrated into new drug formulations, herbal therapies, and preventative treatments. The sector's focus on continuous R&D further propels the demand for botanical inputs.

U.S. Medicinal and Aromatic Plant Market accounted for the largest share, valued at USD 82.3 billion in 2024, with expected growth at a CAGR of 6.3% through 2034. Strong agricultural and distribution infrastructure enables reliable supply chains and high-quality output across the medicinal and aromatic plant sector. Consumer preference for herbal, non-synthetic remedies is high, supported by a trusted regulatory environment that assures quality and safety.

Prominent companies shaping the competitive landscape of this market include Forest Essential, Emami Limited, doTERRA International, Givaudan SA, and Dabur India Limited. To secure a competitive edge, companies in the medicinal and aromatic plant market are focusing on vertical integration and investment in organic farming practices. Many are expanding production facilities, partnering with local growers, and enhancing processing capabilities to ensure consistent quality and traceability. They are also leveraging technological advancements in extraction and purification to deliver high-potency plant-based ingredients. Building trust through clean labeling, sustainable sourcing, and transparency in supply chains remains central. Additionally, companies are targeting international markets through customized product lines and strategic collaborations to grow global reach and reinforce their foothold.

Chapter 1 Methodology

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Regional
- 2.2.2 Plant type
- 2.2.3 Product form
- 2.2.4 Application
- 2.2.5 Cultivation method
2.3 TAM Analysis, 2025-2034
2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
2.5 Future outlook and strategic recommendations

Chapter 3 Industry insights

3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing demand for natural and organic products
  - 3.2.1.2 Increasing healthcare awareness and preventive medicine
  - 3.2.1.3 Rising adoption in pharmaceutical industry
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Supply chain vulnerabilities
  - 3.2.2.2 Climate change impact on cultivation
- 3.2.3 Market opportunities
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
3.5 Porter’s analysis
3.6 PESTEL analysis
3.7 Price trends
- 3.7.1 By region
- 3.7.2 By plant type
3.8 Future market trends
3.9 Technology and Innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
3.10 Patent Landscape
3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
- 4.2.1 By region
  - 4.2.1.1 North America
  - 4.2.1.2 Europe
  - 4.2.1.3 Asia Pacific
  - 4.2.1.4 LATAM
  - 4.2.1.5 MEA
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New product launches
- 4.6.4 Expansion plans

Chapter 5 Market Estimates & Forecast, By Plant Type, 2021-2034 (USD Billion) (Kilo Tons)

5.1 Key trend
5.2 Medicinal Plants
- 5.2.1 Adaptogenic Plants
  - 5.2.1.1 Ashwagandha (Withania somnifera)
  - 5.2.1.2 Ginseng (Panax species)
  - 5.2.1.3 Rhodiola (Rhodiola rosea)
- 5.2.2 Anti-inflammatory Plants
  - 5.2.2.1 Turmeric (Curcuma longa)
  - 5.2.2.2 Ginger (Zingiber officinale)
  - 5.2.2.3 Boswellia (Boswellia serrata)
- 5.2.3 Digestive Health Plants
  - 5.2.3.1 Aloe Vera (Aloe barbadensis)
  - 5.2.3.2 Peppermint (Mentha piperita)
  - 5.2.3.3 Chamomile (Matricaria chamomilla)
- 5.2.4 Respiratory Health Plants
  - 5.2.4.1 Eucalyptus (Eucalyptus globulus)
  - 5.2.4.2 Thyme (Thymus vulgaris)
  - 5.2.4.3 Licorice (Glycyrrhiza glabra)
- 5.2.5 Cardiovascular Health Plants
- 5.2.6 Immune Support Plants
- 5.2.7 Cognitive Health Plants
5.3 Aromatic Plants
- 5.3.1 Essential Oil Plants
  - 5.3.1.1 Lavender (Lavandula angustifolia)
  - 5.3.1.2 Tea Tree (Melaleuca alternifolia)
  - 5.3.1.3 Rosemary (Rosmarinus officinalis)
  - 5.3.1.4 Oregano (Origanum vulgare)
- 5.3.2 Fragrance Plants
  - 5.3.2.1 Rose (Rosa species)
  - 5.3.2.2 Jasmine (Jasminum species)
  - 5.3.2.3 Sandalwood (Santalum album)
- 5.3.3 Culinary Herbs
  - 5.3.3.1 Basil (Ocimum basilicum)
  - 5.3.3.2 Sage (Salvia officinalis)
  - 5.3.3.3 Cinnamon (Cinnamomum species)

Chapter 6 Market Estimates & Forecast, By Product Form, 2021-2034 (USD Billion) (Tons)

6.1 Key trends
6.2 Raw materials
- 6.2.1 Fresh plants and herbs
- 6.2.2 Dried plants and powders
- 6.2.3 Plant parts (roots, leaves, flowers, seeds)
6.3 Extracts and concentrates
- 6.3.1 Standardized extracts
- 6.3.2 Liquid extracts and tinctures
- 6.3.3 Concentrated powders
- 6.3.4 Oleoresins and resins
6.4 Essential oils
- 6.4.1 Pure essential oils
- 6.4.2 Blended essential oils
- 6.4.3 Organic essential oils
- 6.4.4 Therapeutic grade oils
6.5 Finished products
- 6.5.1 Capsules and tablets
- 6.5.2 Liquid formulations
- 6.5.3 Topical applications
- 6.5.4 Functional food products

Chapter 7 Market Estimates & Forecast, By Application, 2021-2034 (USD Billion) (Tons)

7.1 Key trend
7.2 Pharmaceutical industry
- 7.2.1 Drug development and manufacturing
- 7.2.2 Nutraceuticals and dietary supplements
- 7.2.3 Traditional medicine formulations
- 7.2.4 Clinical research and development
7.3 Cosmetics and personal care
- 7.3.1 Skincare products
- 7.3.2 Hair care products
- 7.3.3 Fragrance and perfumery
- 7.3.4 Natural and organic cosmetics
7.4 Food and beverage industry
- 7.4.1 Functional foods and beverages
- 7.4.2 Natural flavoring agents
- 7.4.3 Food preservation and additives
- 7.4.4 Herbal teas and infusions
7.5 Aromatherapy and wellness
- 7.5.1 Essential oil therapy
- 7.5.2 Spa and wellness centers
- 7.5.3 Home aromatherapy products
- 7.5.4 Therapeutic applications
7.6 Agriculture and veterinary
- 7.6.1 Biopesticides and plant protection
- 7.6.2 Animal health and nutrition
- 7.6.3 Organic farming applications
- 7.6.4 Soil health and enhancement

Chapter 8 Market Estimates & Forecast, By Cultivation Method, 2021-2034 (USD Billion) (Tons)

8.1 Key trends
8.2 Conventional cultivation
- 8.2.1 Traditional farming methods
- 8.2.2 Commercial plantation systems
- 8.2.3 Integrated farming approaches
8.3 Organic cultivation
- 8.3.1 Certified organic production
- 8.3.2 Biodynamic farming
- 8.3.3 Natural farming methods
8.4 Wild harvesting
- 8.4.1 Sustainable wild collection
- 8.4.2 Forest-based harvesting
- 8.4.3 Community-based collection
8.5 Controlled environment agriculture
- 8.5.1 Greenhouse cultivation
- 8.5.2 Hydroponic systems
- 8.5.3 Vertical farming applications
- 8.5.4 Tissue culture and micropropagation

Chapter 9 Market Estimates & Forecast, By Region, 2021-2034 (USD Billion) (Tons)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East & Africa